ODAC Dermatology, Aesthetic and Surgical Conference
Target Audience
Learning Objectives
Upon completion of this activity, participants will be able to:
- Define intrinsic and extrinsic factors of the normal aging process in patients with all skin types;
- Select and formulate the appropriate aesthetic treatment plan using neurotoxins, dermal fillers, laser and light-based energy therapy technologies and cosmeceutical products in patients of all skin types who seek improvement in facial and skin appearance;
- Compare patient selection, choice of injectable products and technique required to avoid potential complications and achieve optimal patient outcomes;
- Express current understanding of the pathophysiology of acne as it relates to effective diagnosis and treatment;
- Discuss current theories on the pathogenesis of rosacea including the identification of genetic factors and gene loci that predispose affected patients to a rosacea phenotype;
- Analyze evidence-based data on acne treatment options in order to improve treatment outcomes and improve patient adherence to therapy;
- Examine emerging clinical and therapeutic science insights into the pathogenesis and effective management of atopic dermatitis and summarize the recently published AAD clinical guidelines on the management of atopic dermatitis;
- Discuss the role of the innate and adaptive immune system function in normal skin and how changes in the immune system may contribute to inflammatory disease;
- Identify the psoriasis patient population that would benefit most from treatment with biologic response modifiers;
- Assess evidence-based data on the relationship between psoriasis comorbidities and therapeutic selection;
- Indicate the types of superficial fungal infection presenting in the dermatology setting
- Formulate optimal treatment plans for difficult to treat onychomycosis and cutaneous superficial fungal infections including tinea pedis, tinea cruris and tinea corporis;
- Summarize current and emerging therapies that hold promise for the effective treatment of skin cancers including actinic keratosis, basal cell carcinoma and melanoma.
- 30.00 AMA PRA Category 1 Credit™
- 30.00 Participation
Travel
BOOKING NOW AVAILABLE!
Discount hotel rates available for attendees!
Visit the ODAC 2018 website here, to get more information on booking.
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at 646-746-4339 or via email at donald.morcone@sanovaworks.com.
CONFERENCE CHAIRS
Professor Emeritus of Dermatology
New York University School of Medicine
New York, NY
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with anycommercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago and the Physicians Continuing Education Corporation. The University of Chicago is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 30 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.